13F

Stock

Entera Bio Ltd.

ENTX · held by 22 managers

Reported value

$18.1M

Holders

22

+0 new · −0 exited

Holders’ est. mark

$300

Price effect on 1 books still in the name

Largest holder

$11.4M

Knoll Capital Management, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Knoll Capital Management, LLC5.88M$11.4M—Held
Point72 Asset Management, L.P.1.19M$2.32M—Held
MARSHALL WACE, LLP627.3K$1.22M—Held
Schonfeld Strategic Advisors LLC596.6K$1.16M—Held
Parkman Healthcare Partners LLC275.1K$533.6K—Held
NORTHERN TRUST CORP148.7K$288.4K—Held
Seven Fleet Capital Management LP135.3K$262.5K—Held
Renaissance Technologies108K$209.5K—Held
JANE STREET GROUP, LLC74.1K$143.7K—Held
SUSQUEHANNA INTERNATIONAL GROUP, LLP64.9K$125.9K—Held
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC47.3K$91.8K—Held
HighTower Advisors, LLC43.1K$83.7K—Held
Citadel40.2K$78K—Held
GEODE CAPITAL MANAGEMENT, LLC21.1K$41K—Held
Gem Investment Advisors, LLC19.1K$37.1K—Held
SUPERSTRING CAPITAL MANAGEMENT LP17.1K$33.3K—Held
BANK OF AMERICA CORP /DE/15K$29.1K$300Cut−$11.2K
GOLDMAN SACHS GROUP INC12.3K$23.9K—Held
PNC Financial Services Group, Inc.10K$19.4K—Held
GROUP ONE TRADING LLC51$99—Held
UBS Group AG17$33—Held
GSA CAPITAL PARTNERS LLP11.9K$23—Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.